Axalbion is developing novel therapeutics targeting TRPM-8 Receptors for the treatment of Chronic Cough and other indications........
0 entries
0 comments
Building
Building C
Address
EPFL Innovation Park Building C 1015 Lausanne
Name
Axalbion SA
Company Type
Start-up / SME
Contact Person
Olivier Poirot
Email
contact@axalbion.com
About / Bio / Mission
Axalbion is developing novel therapeutics targeting TRPM-8 Receptors for the treatment of Chronic Cough and other indications.....
Founding Year
2017
Sectors
Biotech
Activity Keywords
Pharmaceutical Development
Number of collaborators
1 - 5
Jobs Offers